Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereof
US8022077B2 · kind B2 · utility
29Cited by
1References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 12, 2006 |
| Grant date | Sep 20, 2011 |
| Priority date | — |
| Expiry date | May 12, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of pyrido[2,3-d]pyrimidines of formula (I)wherein L, R1, R2 and R3 have specific meaning. The present invention also relates to the use of the compounds of formula (I) as inhibitors of HCV replication as well as their use in pharmaceutical compositions aimed to treat or combat HCV infections. In addition, the present invention relates to compounds of formula (I) per se and their use as medicines. The present invention also concerns processes for the preparation of such compounds, pharmaceutical compositions comprising them, and combinations of said compounds with other anti-HCV agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.